• Afero has entered into a partnership with Therma Bright Inc to bring Afero’s tracking technology to Therma Bright’s COVID-19 rapid antigen screening test
  • AcuVid™ COVID-19 Rapid Antigen Saliva Tests will include encryption technology for tracking and reporting test results
  • An encrypted QR Code solution will be embedded on each Acuvid Rapid Antigen Test for both enterprise and consumer use
  • This partnership also paves the way for preparing the AcuVID COVID-19 Rapid Antigen Test for approval for at-home testing
  • Therma Bright is a progressive medical device technology company
  • Therma Bright Inc. (THRM) is unchanged, trading at C$0.44 per share at 11:30 am ET

Afero has partnered with Therma Bright (THRM) to bring Afero’s tracking technology to Therma Bright’s COVID-19 rapid antigen screening test.

The partnership aims to bring Afero’s innovation, security and tracking technology to Therma Bright’s 15-minute COVID-19 rapid antigen screening test.

Upon completion, the proposed agreement will offer AcuVid™ COVID-19 Rapid Antigen Saliva Tests powered by Afero, enhanced with encryption technology for tracking and reporting AcuVID test results.

This partnership also paves the way for preparing the AcuVID COVID-19 Rapid Antigen Test for approval for at-home testing. The MOU was completed and signed on April 28, 2021. Both parties expect to complete a definitive agreement and begin work on or before June 1, 2021.

Backed by the fifth largest IoT patent portfolio globally, the Afero Platform gives partners an agile development process, best-in-class security, and rapid data capture across multiple products and product generations.

Afero’s mobile application supports advanced quality control features and an intuitive user experience. With the secure Afero Cloud, AcuVid™ test status is tracked and managed on a real-time basis for many millions of tests deployed around the world. And with secure Afero Integrations, millions of test results can be shared with government agencies, workplaces, entertainment venues and more.

Even with the proliferation of COVID-19 vaccines across the United States and Canada, the need for secure and reliable rapid antigen testing remains critical to help in slowing the spread of the original COVID19 virus, along with a growing list of variants.

The Afero encrypted QR Code solution will be embedded on each Acuvid Rapid Antigen Test for both enterprise and consumer use. Therma Bright will be able to use this tracking technology for quality assurance and logistics tracking as well as reporting results in a safe, secure manner first for point-of-care facilities, and then for at-home use.

“Our AcuVid COVID-19 Rapid Antigen Test, powered by Afero, will provide users our “Brighter Experience” – a complete end-to-end solution to ensure product tracking, quality control and test validation data are all cryptographically captured and secured to protect individual privacy for every test taken,” explained Rob Fia, CEO of Therma Bright.

“By integrating Afero’s Secure QR Code technology, each AcuVid test deployed will be validated for its efficacy and confirmed on the Afero-powered mobile application. All data captured will be securely stored in the Afero Cloud. If accepted by the end user, their test results can then be transmitted to their personal healthcare practitioner, and/or to their mobile health wallet for ease of use and test verification.”

“The opportunity to work with Therma Bright to help mitigate community spread of COVID-19 is a critical step in the growth of our intelligent edge technology,” said Joe Britt, Afero co-founder and CEO.

“Therma Bright’s AcuVid COVID-19 Rapid Antigen Test, powered by Afero, is measurable progress towards enabling everyone on the planet to be able to take a secure, simple, reliable saliva-based test. Afero’s expertise in user validation, security, data management and data analytics serve as a critical platform for deploying a “smart” AcuVid solution which reduces risk and adds a layer of quality control which currently doesn’t exist with other rapid tests.”

The Afero next-generation Intelligent Edge platform provides hardened security from devices to the cloud.

Ridge Global works with C-suite executives and corporate directors to reduce enterprise risk and to build more resilient organizations through innovative preparedness, protection, response and education capabilities.

Therma Bright is a progressive medical device technology company focused on providing consumers and medical professionals with quality medical devices that address their medical and healthcare needs.

Therma Bright Inc. (THRM) is unchanged, trading at C$0.44 per share at 11:30 am ET.

More From The Market Online
BriaCell Therapeutics Corp

BriaCell to report positive cancer research at medical convention

BriaCell Therapeutics (TSX:BCT) will present positive clinical data of Bria-IMT at the 2024 American Society of Clinical Oncology in Chicago.

Despite cybersecurity breach, Mainstreet Equity stock is a buy

Mainstreet Equity (TSX:MEQ), a highly profitable property manager with almost 18,000 units, suffered a cybersecurity breach on Tuesday.

@ the Bell: TSX gains on latest economic report

Mining stocks led gainers on the TSX, followed by the financial sector, while the telecom market was the biggest decliner.

BC Transit orders 29 zero-emission buses from NFI subsidiary

NFI Group Inc. (TSX:NFI) subsidiary Alexander Dennis Ltd. receives a firm order for 29 zero-emission Enviro500EV buses from BC Transit.